UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2017-12, Vol.377 (25), p.2433-2444

2017

Volltextzugriff (PDF)

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Transplantation, 2013-08, Vol.96 (4), p.333-360

2013

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplantation

American journal of transplantation, 2013-03, Vol.13 (s4), p.93-106

2013

Volltextzugriff (PDF)

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

American journal of transplantation, 2017-09, Vol.17 (9), p.2468-2473

2017

Volltextzugriff (PDF)

Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence

The Journal of infectious diseases, 2020-03, Vol.221 (Supplement_1), p.S23-S31

2020

Volltextzugriff (PDF)

Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients

Cochrane database of systematic reviews, 2007-04 (2), p.CD005129

2007

Volltextzugriff (PDF)

CMV: Prevention, Diagnosis and Therapy

American journal of transplantation, 2013-02, Vol.13 (s3), p.24-40

Kotton, C. N.

2013

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplant Recipients

American journal of transplantation, 2009-12, Vol.9, p.S78-S86

2009

Volltextzugriff (PDF)

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection After Transplantation

Drugs (New York, N.Y.), 2018-07, Vol.78 (11), p.1085-1103

2018

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779-795

2010

Volltextzugriff (PDF)

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

American journal of transplantation, 2020-06, Vol.20 (6), p.1703-1711

2020

Volltextzugriff (PDF)

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2014-05, Vol.370 (19), p.1781-1789

2014

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

American journal of transplantation, 2019-02, Vol.19 (2), p.573-584

2019

Volltextzugriff (PDF)

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Transplant infectious disease, 2019-12, Vol.21 (6), p.e13187-n/a

2019

Volltextzugriff (PDF)

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2013-09, Vol.369 (13), p.1227-1236

2013

Volltextzugriff (PDF)

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.290-299

2012

Volltextzugriff (PDF)

The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Transplantation, 2023-08, Vol.107 (8), p.1671-1672

Kotton, Camille Nelson

2023

Volltextzugriff (PDF)

A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial

Transplantation, 2024-01, Vol.108 (1), p.261

2024

Volltextzugriff (PDF)

Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients

Annual review of medicine, 2023-01, Vol.74 (1), p.89-105

2023

Volltextzugriff (PDF)

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

American journal of transplantation, 2015-10, Vol.15 (10), p.2655-2664

2015

Volltextzugriff (PDF)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Transplantation, 2023-08, Vol.107 (8), p.1846-1853

2023

Volltextzugriff (PDF)

Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial

Transplantation, 2023-08, Vol.107 (8), p.1835-1845

2023

Volltextzugriff (PDF)

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

American journal of transplantation, 2020-08, Vol.20 (8), p.2070-2080

2020

Volltextzugriff (PDF)

1 – 25 von 1.078

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Journal Of Heart And Lung Transplantation

Zeitschrift / SerieTransplantation Proceedings

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.000)
Mit Volltextzugriff
(775)

Publikationsform

Artikel
(1.078)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.046)
Humans
(1.045)
Life Sciences & Biomedicine
(1.040)
Cytomegalovirus Infections - Prevention & Control
(818)
Cytomegalovirus
(704)
Female
(599)
Male
(594)
Immunology
(590)
Adult
(546)
Middle Aged
(510)
Antiviral Agents - Therapeutic Use
(420)
Surgery
(419)
Biological And Medical Sciences
(409)
Medical Sciences
(404)
Risk Factors
(316)
Infectious Diseases
(296)
Retrospective Studies
(278)
Ganciclovir - Therapeutic Use
(275)
Adolescent
(265)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Cytomegalovirus in Solid Organ Transplantation

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence

Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients

CMV: Prevention, Diagnosis and Therapy

Cytomegalovirus in Solid Organ Transplant Recipients

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

New Developments in the Management of Cytomegalovirus Infection After Transplantation

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial

Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

Aktive Filter

Suchergebnisse filtern